Literature DB >> 22044384

Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems.

Susanne Brauninger1, Heike Bialleck, Kristin Thorausch, Tom Felt, Erhard Seifried, Halvard Bonig.   

Abstract

BACKGROUND: Granulocyte-colony-stimulating factor-mobilized peripheral blood stem cells, collected by white blood cell apheresis, are used for more than 80% of allogeneic and most autologous hematopoietic stem cell transplantations. Optimal donor and recipient outcomes require maximized stem cell collection efficiency and minimized non-target cell contamination. Therefore, improved apheresis technology is desirable. The safety and feasibility of apheresis collections with the novel, electronics-assisted apheresis system Spectra Optia v.5.0 (CaridianBCT) were recently demonstrated. An unpublished optimization trial had furthermore determined that different settings than manufacturer-installed default might result in improved apheresis yields. STUDY DESIGN AND METHODS: The first prospective comparison of allogeneic peripheral blood stem cell apheresis with the Spectra Optia versus the COBE Spectra (CaridianBCT) mononuclear cell (MNC) in a routine clinical setting is reported here; "optimized" machine settings were used. Assessed variables included collection efficiency, product characteristics, donor outcomes, and frequency of operator interventions. Outcomes were additionally compared with historical data from the Spectra Optia in default mode.
RESULTS: The mean CD34+ cell collection efficiency CE1 was 7.9% greater with the Spectra Optia than with the COBE Spectra MNC. Variability of outcomes was equally great. Reduced platelet (PLT) attrition necessitated 90% fewer autologous PLT reinfusions. Spectra Optia products contained 50% fewer red blood cells, but 50% more granulocytic lineage cells. Less operator input was required, although 26% of Spectra Optia apheresis procedures required triggering of the first chamber flush. Apheresis yield and collection efficiency were also markedly greater than in default-mode Spectra Optia collections.
CONCLUSION: Using optimized machine settings, peripheral blood stem cell apheresis outcomes with the automated apheresis system Spectra Optia exceed results with the COBE Spectra MNC or the Spectra Optia in the default mode.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044384     DOI: 10.1111/j.1537-2995.2011.03414.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

Review 1.  Stem cell recruitment after injury: lessons for regenerative medicine.

Authors:  Robert C Rennert; Michael Sorkin; Ravi K Garg; Geoffrey C Gurtner
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

2.  Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy Donors.

Authors:  Hans-Gert Heuft; Eike Fischer; Tina Weingand; Thomas Burkhardt; Gerda Leitner; Hagen Baume; Jörg-Peter Schmidt; Andreas Buser; Gabriele Fauchald; Ute Reinicke Voigt; Behrouz Mansouri-Taleghani
Journal:  Transfus Med Hemother       Date:  2016-11-28       Impact factor: 3.747

Review 3.  CAR-T Cell Therapies From the Transfusion Medicine Perspective.

Authors:  Andrew Fesnak; ChieYu Lin; Don L Siegel; Marcela V Maus
Journal:  Transfus Med Rev       Date:  2016-03-28

4.  A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience.

Authors:  Serife Solmaz; Selda Kahraman; Omur Gokmen Sevindik; Celal Acar; Munire Turkyilmaz; Inci Alacacioglu; Ozden Piskin; Mehmet Ali Ozcan; Hayri Guner Ozsan; Bulent Undar; Fatih Demirkan
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-23       Impact factor: 0.900

Review 5.  Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.

Authors:  Olivier Hequet
Journal:  J Blood Med       Date:  2015-02-18

6.  Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure.

Authors:  Christiane Hümmer; Carolin Poppe; Milica Bunos; Belinda Stock; Eva Wingenfeld; Volker Huppert; Juliane Stuth; Kristina Reck; Mike Essl; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2016-03-16       Impact factor: 5.531

7.  Activation of Notch1 signaling alleviates dysfunction of bone marrow-derived mesenchymal stem cells induced by cigarette smoke extract.

Authors:  Yi Cheng; Wen Gu; Guorui Zhang; Xiaoming Li; Xuejun Guo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-27

Review 8.  Genetic Engineering and Manufacturing of Hematopoietic Stem Cells.

Authors:  Xiuyan Wang; Isabelle Rivière
Journal:  Mol Ther Methods Clin Dev       Date:  2017-03-18       Impact factor: 6.698

Review 9.  The multi-differentiation potential of peripheral blood mononuclear cells.

Authors:  Min Zhang; Bing Huang
Journal:  Stem Cell Res Ther       Date:  2012-11-30       Impact factor: 6.832

10.  Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor.

Authors:  Guro Kristin Melve; Elisabeth Ersvaer; Çiğdem Akalın Akkök; Aymen Bushra Ahmed; Einar K Kristoffersen; Tor Hervig; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2016-07-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.